Cargando…
A novel, polymer-coated oncolytic measles virus overcomes immune suppression and induces robust antitumor activity
Although various therapies are available to treat cancers, including surgery, chemotherapy, and radiotherapy, cancer has been the leading cause of death in Japan for the last 30 years, and new therapeutic modalities are urgently needed. As a new modality, there has recently been great interest in on...
Autores principales: | Nosaki, Kaname, Hamada, Katsuyuki, Takashima, Yuto, Sagara, Miyako, Matsumura, Yumiko, Miyamoto, Shohei, Hijikata, Yasuki, Okazaki, Toshihiko, Nakanishi, Yoichi, Tani, Kenzaburo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091787/ https://www.ncbi.nlm.nih.gov/pubmed/27847861 http://dx.doi.org/10.1038/mto.2016.22 |
Ejemplares similares
-
Extremely Low Organ Toxicity and Strong Antitumor Activity of miR-34-Regulated Oncolytic Coxsackievirus B3
por: Jia, Yang, et al.
Publicado: (2019) -
Coxsackievirus A11 is an immunostimulatory oncolytic virus that induces complete tumor regression in a human non-small cell lung cancer
por: Sakamoto, Akira, et al.
Publicado: (2023) -
A phase I clinical trial of RNF43 peptide-related immune cell therapy combined with low-dose cyclophosphamide in patients with advanced solid tumors
por: Hijikata, Yasuki, et al.
Publicado: (2018) -
Measles to the Rescue: A Review of Oncolytic Measles Virus
por: Aref, Sarah, et al.
Publicado: (2016) -
Measles Virus as an Oncolytic Immunotherapy
por: Engeland, Christine E., et al.
Publicado: (2021)